Charles River Laboratories International Aktie
177,40
EUR
+2,75
EUR
+1,57
%
186,18
USD
+0,78
USD
+0,42
%
Charles River Laboratories International Aktie Analyse
14.12.18 | Charles River Laboratories International Buy | Deutsche Bank AG | |
26.04.16 | Charles River Laboratories International Buy | Gabelli & Co | |
13.05.10 | Charles River Laboratories International kaufen | Robert W. Baird & Co. Incorporated | |
02.05.07 | Charles River Laboratories International outperform | Robert W. Baird | |
17.04.07 | Charles River Laboratories International overweight | Lehman Brothers | |
15.02.07 | Charles River Laboratories International buy | Jefferies & Co | |
04.05.06 | Charles River Laboratories International overweight | Lehman Brothers | |
04.05.06 | Charles River Laboratories International Overweight | Lehman Brothers | |
Werbung
|
|||
13.12.05 | Charles River Laboratories International | Biotech-Report | |
27.10.05 | Charles River Laboratories International outperform | Goldman Sachs | |
27.10.05 | Charles River Laboratories International Outperform | Goldman Sachs |